zintick

Olema Pharmaceuticals OLMA

Olema Pharmaceuticals, Inc. · Nasdaq · Pharmaceutical Preparations

$7.49+6.39%close on Oct. 28, 2026 · volume 1.4M · Yahoo Finance

Price, last 47 sessions

$8.00$10.00Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 28, 2026 · high $10.99 · low $6.41 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
July 24, 2026Cyrus Harmon
director
Sold12,500$11.71$146,425
July 23, 2026Cyrus Harmon
director
Sold12,500$11.58$144,738

Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 9 →
  • SCHEDULE 13D/AOct. 16, 2026, 5:58 p.m. ETView on SEC.gov
  • 8-KOct. 15, 2026, 5 p.m. ETView on SEC.gov

    Departure/appointment of directors or officers

  • 4Sept. 2, 2026, 4:30 p.m. ETView on SEC.gov
  • 8-KAug. 13, 2026, 7:05 a.m. ETView on SEC.gov

    Departure/appointment of directors or officers · Regulation FD disclosure · Financial statements and exhibits

  • 10-QAug. 10, 2026, 4:10 p.m. ETView on SEC.gov
  • 8-KAug. 10, 2026, 4:05 p.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits

  • SCHEDULE 13G/AAug. 6, 2026, 10:33 a.m. ETView on SEC.gov
  • SCHEDULE 13G/AJuly 29, 2026, 3:19 p.m. ETView on SEC.gov